Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

T47D cells Anastrozole RNA-seq

ABSTRACT: T47D cells Anastrozole RNA-seq

PROVIDER: PRJNA633145 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11798588_1.fastq.gz	Fastqsanger.gz
	SRR11798588_2.fastq.gz	Fastqsanger.gz
	SRR11798589_1.fastq.gz	Fastqsanger.gz
	SRR11798589_2.fastq.gz	Fastqsanger.gz
	SRR11798590_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

T47D cells; Anastrozole RNA-seq

Project description:The objective of the RNAseq is to identify genes regulated by anastrozole, and the difference in genes regulated by anastrozole and estradiol.

2020-09-08 | GSE150683 | GEO

T47D RNA-seq and ChrRNA-seq data

Project description:T47D RNA-seq and ChrRNA-seq data

| PRJNA415425 | ENA

T47D RNA-seq and ChrRNA-seq data

Project description:We performed genome-wide RNA-seq and ChrRNA-seq experiments in T47D cell lines after PADI2 knock down . Both the mRNA and chromatin RNA seq peformed in sicontrol and siPADI2 as in biological replicates . Also we performed mRNA seq in T47D cells expressing HA Tagged amanitin resistant wild type in comparison to R1810A mutant form of RNAP2.

2018-11-21 | GSE105792 | GEO

RNA-seq transcriptome analyses in T47D cells treated with ActA and Palbociclib.

Project description:We performed SMAD2 ChIP-seq analysis in T47D cells with/without Palbociclib treatment. To validate whether the changes in SMAD2 binding to the genome indeed resulted in changes in target gene expression, we performed RNA-seq transcriptome analyses in T47D with/without ActA stimulation and Palbo treatment.

2018-10-23 | GSE117497 | GEO

RNA-seq analysis of AKTi MK2206 resistant BT474 and T47D cells

Project description:RNA-seq analysis of AKTi MK2206 resistant BT474 and T47D cells

| PRJNA484709 | ENA

Nascent RNA sequencing (PRO-seq) after estrogen treatment in T47D cells

Project description:Nascent RNA sequencing (PRO-seq) after estrogen treatment in T47D cells

| PRJNA764248 | ENA

Nascent RNA sequencing (PRO-seq) after various treatments in T47D cells

Project description:Nascent RNA sequencing (PRO-seq) after various treatments in T47D cells

| PRJNA1055459 | ENA

Project description:We report the comprehensive genome-wide binding peaks for key factors inovled in oxygen sensing pathways, such as HIF1α, HIF1β and EglN2. In addition, we also report the genome-wide binding peaks for NRF1 in breast cancer cells We conducted HA-EglN2, HIF1α, HIF1β (ARNT) or NRF1 ChIP-Seq in the T47D cell line that overexpresses HA-EglN2 in the presence of hypoxia (1%) and DMOG treatment. T47D parental cells treated with the same condition followed by HA ChIP-seq served as the control to filter non-specific binding.

2014-07-31 | E-GEOD-59935 | biostudies-arrayexpress

Messenger RNA expression after MK2206/DMSO treatment of T47D cells

Project description:We performed RNA-seq in T47D cells after 24 hour treatment with the AKT inhibitor MK2206 or DMSO. We show that a group of transcripts is differentailly expressed after AKT inhibition. Comparison of mRNA levels using RNA-seq after AKT inhibition vs vehicle

2016-06-14 | E-GEOD-80591 | biostudies-arrayexpress

RNA-seq of ERINA knockdown T47D cell lines

Project description:RNA-seq of ERINA knockdown T47D cell lines

| PRJNA622513 | ENA